Clinical Trial Update: Cannabidiol for Reduction of Brain Neuroinflammation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by Massachusetts General Hospital is evaluating cannabidiol for reducing brain neuroinflammation and is currently recruiting.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Back Pain
• Major Depressive Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Back Pain, Depressive Symptoms | Phase 2 | Status: RECRUITING